The public health genomics translation gap: What we don't have and why it matters

Public Health Genomics

Volumn 15, Issue 3-4, 2012, Pages 132-138

  Williams, M S ^a  

^a INTERMOUNTAIN HEALTHCARE   (United States)

Author keywords

Evidence based health; Genomics; Health care delivery research; Health care policy; Implementation; Public health; Translational research

Indexed keywords

CONFERENCE PAPER; GENOMICS; GENOTYPE ENVIRONMENT INTERACTION; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH EDUCATION; HUMAN; HUMAN GENOME; MEDICAL CARE; PATIENT CARE; PRIORITY JOURNAL; PRIVACY; PUBLIC HEALTH SERVICE; REIMBURSEMENT; UNITED STATES; WORKER;

BREAST NEOPLASMS; EVIDENCE-BASED MEDICINE; FEMALE; GENOME, HUMAN; GENOMICS; HEALTH POLICY; HUMANS; INDIVIDUALIZED MEDICINE; INFANT, NEWBORN; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; NEONATAL SCREENING; OVARIAN NEOPLASMS; PHARMACOGENETICS; PUBLIC HEALTH; PUBLIC HEALTH PRACTICE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84859590638     PISSN: 16624246     EISSN: 16628063     Source Type: Journal    
DOI: 10.1159/000334341     Document Type: Conference Paper

References (49)

1. Hall SS: Revolution postponed. Sci Am 2010;303:60-67.
2. Botkin JR, Teutsch SM, Kaye CI, Hayes M, Haddow JE, Bradley LA, Szegda K, Dotson WD; EGAPP Working Group: Outcomes of interest in evidence-based evaluations of genetic tests. Genet Med 2010;12:228-235.
3. Guttmacher AE, Porteous ME, McInerney JD: Educating health-care professionals about genetics and genomics. Nat Rev Genet 2007;8:151-157. (Pubitemid 46122843)
4. Johnson JD, Case DO, Andrews JE, Allard SL: Genomics-the perfect information-seeking research problem. J Health Commun 2005;10:323-329. (Pubitemid 40980948)
5. Silvers A, Stein MA: Human rights and genetic discrimination: protecting genomics'promise for public health. J Law Med Ethics 2003;31:377-389. (Pubitemid 39307074)
6. Williams MS: Insurance coverage for pharmacogenomic testing. Per Med 2007;4:479-487.
7. Schully SD, Benedicto CB, Gillanders EM, Wang SS, Khoury MJ: Translational research in cancer genetics: the road less traveled. Public Health Genomics 2011;14:1-8.
8. Committee on Quality of Health Care in America, Institute of Medicine: Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, National Academy Press, 2001.
9. Thomson R, Bhopal R: Improving quality of health care: the role of public health medicine. Qual Health Care 1993;2:35-39.
10. Bryant KG, Horns KM, Longo N, Schiefelbein J: A primer on newborn screening. Adv Neonatal Care 2004;4:306-317. (Pubitemid 39446352)
11. Therrell BL, Lloyd-Puryear MA, Mann MY: Understanding newborn screening system issues with emphasis on cystic fibrosis screening. J Pediatr 2005;147(suppl 3):S6-10.
12. U.S. Department of Health and Human Services. http://www.hrsa.gov/ advisorycommittees/ mchbadvisory/heritabledisorders/ about/saveslives.pdf (accessed October 20, 2011).
13. Health Resource and Service Administration: Baby's First Test. http://www.nbsclearinghouse. org (accessed August 18, 2011).
14. U.S. Preventive Services Task Force: Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility. http://www.uspreventiveservicestaskforce. org/uspstf/uspsbrgen.htm (accessed August 18, 2011).
15. AETNA News Releases: http://www.aetna. com/news/newsReleases/2010/0915- BRCA-Testing. html (accessed August 18, 2011).
16. Duquette D, Langbo C, Bach J, Kleyn M: Michigan BioTrust for Health: public support for using dried blood spot samples for health research. Public Health Genomics 2012;15:146-155.
17. Teng K: Pharmacogenomics for the primary care provider: why should we care? Cleve Clin J Med 2011;78:241-242.
18. Becquemont L, Alfirevic A, Amstutz U, Brauch H, Jacqz-Aigrain E, Laurent-Puig P, Molina MA, Niemi M, Schwab M, Somogyi AA, Thervet E, Maitland-van der Zee AH, van Kuilenburg AB, van Schaik RH, Verstuyft C, Wadelius M, Daly AK: Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics. Pharmacogenomics 2011;12:113-124.
19. Lesko LJ, Zineh I: DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA. Pharmacogenomics 2010;11:507-512.
20. Deverka PA: Pharmacogenomics, evidence, and the role of payers. Public Health Genomics 2009;12:149-157.
21. Evaluation of Genomic Applications in Practice and Prevention (EGAPP). http://www. egappreviews.org/ (accessed August 18, 2011).
22. Evaluation of Genomic Applications in Practice and Prevention (EGAPP). http://www. egappreviews.org/recommendations/index. htm (accessed August 18, 2011).
23. Pharmacogenomics Knowledge Base. http:// www.pharmgkb.org/ (accessed August 18, 2011).
24. Pharmacogenomics Knowledge Base. http:// www.pharmgkb.org/contributors/ consortia/ cpic-profile.jsp (accessed August 18, 2011).
25. Relling MV, Klein TE: CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin Pharmacol Ther 2011;89:464-467.
26. Scott SA, Sangkuhl K, Gardner EE, Stein CM, Hulot JS, Johnson JA, Roden DM, Klein TE, Shuldiner AR; Clinical Pharmacogenetics Implementation Consortium: Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy. Clin Pharmacol Ther 2011; 90:328-332.
27. Relling MV, Gardner EE, Sandborn WJ, Schmiegelow K, Pui CH, Yee SW, Stein CM, Carrillo M, Evans WE, Klein TE; Clinical Pharmacogenetics Implementation Consortium: Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther 2011;89:387-391.
28. Epstein RS, Moyer TP, Aubert RE, O Kane DJ, Xia F, Verbrugge RR, Gage BF, Teagarden JR: Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study). J Am Coll Cardiol 2010;55:2804-2812.
29. Epstein RS, Teagarden JR: Comparative effectiveness research and personalized medicine: catalyzing or colliding? Pharmacoeconomics 2010;28:905-913.
30. U.S. Department of Health and Human Services. Centers for Medicare and Medicaid Services. http://www.cms.gov/medicarecoverage- database/details/ncd- details.aspx? NCDId=333&ncdver=1&bc=BAAAgAAAA AAA& (accessed August 18, 2011).
31. U.S. Department of Health and Human Services. Genetics Education and Training. http://oba.od.nih.gov/oba/SACGHS/reports/ SACGHS-education-report- 2011. pdf (accessed August 22, 2011).
32. Kemper AR, Trotter TL, Lloyd-Puryear MA, Kyler P, Feero WG, Howell RR: A blueprint for maternal and child health primary care physician education in medical genetics and genomic medicine: recommendations of the United States secretary for health and human services advisory committee on heritable disorders in newborns and children. Genet Med 2010;12:77-80.
33. Hoffman MA, Williams MS: Electronic medical records and personalized medicine. Hum Genet 2011;130:33-39.
34. Federal Register. http://edocket.access.gpo. gov/2010/pdf/2010-17207.pdf (accessed August 22, 2011).
35. Ullman-Cullere MH, Mathew JP: Emerging landscape of genomics in the Electronic Health Record for personalized medicine. Hum Mutat 2011;32:512-516.
36. National Human Genome Research Institute: Electronic Medical Records and Genomics (eMERGE) Network. http://www.genome. gov/27540473 (accessed August, 22, 2011).
37. HMO Research Network. http://www. hmoresearchnetwork.org/about.htm (accessed August 22, 2011).
38. The NIH Common Fund: HMO Collaboratory. http://commonfund.nih.gov/ hmocollaboratory/ (accessed August 22, 2011).
39. Perrin JM, Knapp AA, Browning MF, Comeau AM, Green NS, Lipstein EA, Metterville DR, Prosser L, Queally D, Kemper AR: An evidence development process for newborn screening. Genet Med 2010;12:131-134.
40. U.S. Department of Health and Human Services: Recommended Uniform Screening Panel of the Secretary's Advisory Committee on heritable disorders in newborns and children. http://www.hrsa.gov/advisorycommittees/ mchbadvisory/heritabledisorders/ recommendedpanel/ (accessed October 20, 2011).
41. Khoury MJ, Berg A, Coates R, Evans J, Teutsch SM, Bradley LA: The evidence dilemma in genomic medicine. Health Aff (Millwood) 2008;27:1600-1611.
42. Health Information Technology for Economic and Clinical Health. http://www.hhs. gov/ocr/privacy/hipaa/understanding/coveredentities/ hitechact.pdf (accessed August 22, 2011).
43. Kuperman GJ: Health-information exchange: why are we doing it, and what are we doing? J Am Med Inform Assoc 2011;18:678-682.
44. Ginsburg GS, Willard HF: Genomic and personalized medicine: foundations and applications. Transl Res 2009;154:277-287.
45. Swensen SJ, Meyer GS, Nelson EC, Hunt GC Jr, Pryor DB, Weissberg JI, Kaplan GS, Daley J, Yates GR, Chassin MR, James BC, Berwick DM: Cottage industry to postindustrial care - the revolution in health care delivery. N Engl J Med 2010;362:e12.
46. Dove JT, Weaver WD, Lewin J: Health care delivery system reform: accountable care organizations. J Am Coll Cardiol 2009;54:985-988.
47. James BC, Savitz LA: How Intermountain trimmed health care costs through robust quality improvement efforts. Health Aff (Millwood) 2011;30:1185-1191.
48. Gudgeon JM, Williams JL, Burt RW, Samowitz WS, Snow GL, Williams MS: Lynch Syndrome Screening Implementation: business analysis by a healthcare system. Am J Manag Care 2011;17:e288-300.
49. Pauker SG, Kassirer JP: Decision analysis. N Engl J Med 1987;316:250-258. (Pubitemid 17051051)